β-adrenergic receptors, transgenic mice, and pharmacological model systems

Molecular Pharmacology

Volumn 60, Issue 4, 2001, Pages 629-631

  Port, J David ^a   Bristow, Michael R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; ISOPRENALINE; METOPROLOL; PROPRANOLOL; XAMOTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; GENE OVEREXPRESSION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; INTRINSIC SYMPATHOMIMETIC ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; XAMOTEROL;

EID: 0034802033     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (35)

1. Bucindolol, a nonselective β1- and β2-adrenergic receptor antagonist, decreases β-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes
2. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
3. 1-adrenergic receptor in transgenic mice
4. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor
5. Beta-adrenergic receptor blockade in chronic heart failure
6. What type of beta-blocker should be used to treat chronic heart failure?
7. Baseline and three month change in systemic venous norepinephrine as predictors of clinical outcomes in the BEST Trial
8. Inverse agonist activity of beta-adrenergic antagonists
9. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor
10. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS)
11. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
12. Potentiation of β-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes
13. Constitutive activity of the human β1-adrenergic receptor in β1-receptor transgenic mice
14. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice
15. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene
16. An efficacy-dependent effect of cardiac overexpression of β2-adrenoceptor on ligand affinity in transgenic mice
17. Amplification of cyclic AMP generation reveals agonistic effects of certain β-adrenergic antagonists
18. The stability of the agonist β2-adrenergic receptor-Gs complex: Evidence for agonist-specific states
19. Constitutively active mutants of the beta1-adrenergic receptor
20. Pharmacogenetics of beta-1- and beta-2-adrenergic receptors
21. 2-adrenergic receptor overexpression in mouse hearts: Critical role for expression level
22. Clinical relevance of inverse agonism and guanine nucleotide modulatable binding properties of β-adrenergic receptor blocking agents
23. Differential effects of β-blocking agents on adrenergic activity
24. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium
25. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
26. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor
27. Effect of carvedilol on survival in severe chronic heart failure
28. A mutation-induced active state of the β2-adrenergic receptor
29. Bucindolol has no sympathomimetic activity in nonfailing ventricular preparations
30. 2-adrenergic receptor in the heart: Prospects for molecular ventricular assistance
31. Xamoterol in severe heart failure
32. Cardiac adrenergic receptor effects of carvedilol
33. 2+ current in mouse ventricular myocytes
34. Constitutive beta2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart
35. 2 double knockout mice